OcyonBio Appoints Robert Salcedo as Chief Executive Officer
Published on: Thursday 06 January 2022
OcyonBio will provide preclinical through commercial manufacturing, including process development, viral vectors, cell banking, cell processing, and supporting testing capabilities. The 100,000+ ...
